Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Astragaloside A may help fight lung cancer by targeting specific proteins.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

A new compound shows promise as a topical treatment for hair loss.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Valproic acid may cause hair loss by reducing biotinidase enzyme activity in rats.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

Ruxolitinib treatment may cause eyelash growth.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Low dose valproic acid treatment caused hair loss in a young patient.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Dutasteride effectively treats enlarged prostate with manageable side effects.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.